WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: IBD 5, Signs and symptoms assessment scale includes Rectal bleeding (RB), Friability Score account for Endoscopic findings, Repeated concepts/instances (e.g. Stool Frequency) are denoted by dotted outline, Concepts (e.g. Standardized Procedures) are denoted by solid round-edged rectangle, instance of concepts (e.g. Video equipment) are denoted by solid square-edged rectangle, Responder analysis includes Improvement in endoscopic appearance of mucosa, Stool frequency (SF) assessed between Defined time period, Other Scores account for SF, Other Scores account for Endoscopic findings, Rectal bleeding (RB) quantified by Any blood No blood, Friability Score account for Physicial's global assessment, Other Scores account for RB, FDA Criteria for Efficacy endpoints for UC treatment assessed at Protocol-specific timepoints, Patient reported outcomes (PRO) summarized by Standardized instructions, Signs and symptoms assessment scale has pertinent information Patient reported outcomes (PRO), Scoring of characteristics with subjective elements include Friability Score, Improvement in endoscopic appearance of mucosa measured by Endoscopic assessment scale, Therapeutic Efficacy Point are defined by Observation or Assessment, Responder analysis includes Signs and symptoms assessment scale, Handling discrepancies occur with Central reader